ECSIT and glioblastoma: Therefore, moderate E2F2 gene expression and high or low ECSIT and ID4 gene expression was associated with a lower risk of mortality and disease progression in patients with GBM (except for disease progression at moderate E2F2 expression compared with high E2F2 expression and low ECSIT expression) (Table 3).